Innokin Partners with Bahrain Duty Free for Product Expansion

Market by 2FIRSTS.ai
Aug.31.2023
Innokin Partners with Bahrain Duty Free for Product Expansion
Innokin partners with Bahrain Duty Free to expand sales of its INNOBAR e-cigarette products in Bahrain.

Innokin, a renowned e-cigarette brand, has announced a strategic partnership with Bahrain Duty Free, a well-known retailer in the Middle East, according to a press release from PR Newswire on August 30th. This collaboration will allow Innokin's e-cigarette product, INNOBAR, to be sold through the distribution channels of Bahrain Duty Free.

 

According to reports, Innokin and Bahrain Duty Free launched a pilot project in April 2023. During the trial, all trial stocks were sold out within two weeks. As a result, Innokin expanded its collaboration with Bahrain Duty Free, including more products such as Innokin's INNOBAR device, which is specifically introduced for the Bahrain market.

 

Currently, the INNOBAR 3500, 6000, and V7000 models have been launched in duty-free shops in Bahrain, with popular flavors including dragon fruit, strawberry, and watermelon.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Related Topics